Antibiotics for Prevention of SSI in Obese Women Undergoing CS
NCT ID: NCT03736187
Last Updated: 2018-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
280 participants
INTERVENTIONAL
2019-04-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antibiotic Prophylaxis in Prosthetic Breast Reconstructions
NCT02012517
Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI
NCT04975945
Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.
NCT03502356
Prophylactic Antibiotic in Subtalar Fusion Surgery
NCT06527989
Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis
NCT06005168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cephalexin
Group a will receive cephalexin 1gm before skin incision intravenous
Cephalexin
Giving cephalexin and metronidazole in one group \&cephalexin alone in another group
Cephalexin &metronidazole
Group b will receive cephalexin 1gm intravenous plus 1gm metronidazole rectally before skin incision
Cephalexin
Giving cephalexin and metronidazole in one group \&cephalexin alone in another group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cephalexin
Giving cephalexin and metronidazole in one group \&cephalexin alone in another group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abeer mohammed abd allah elsayed
Cairo governorate,hadaik elqoba,elkhalig elmasry street
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Antibiotics for SSI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.